Cardiac iron overload in transfusion-dependent patients with myelodysplastic syndromes

被引：47

作者：

Roy, Noemi B. A. ^{[1
]}

Myerson, Saul ^{[2
]}

Schuh, Anna H. ^{[3
]}

Bignell, Patricia ^{[3
]}

Patel, Roger ^{[4
]}

Wainscoat, Jim S. ^{[5
]}

McGowan, Simon ^{[6
]}

Marchi, Emanuele ^{[6
]}

Atoyebi, Wale ^{[5
]}

Littlewood, Tim ^{[5
]}

Chacko, Joseph ^{[7
]}

Vyas, Paresh

Killick, Sally B. ^{[7
]}

机构：

[1] John Radcliffe Hosp, Weatherall Inst Mol Med, Mol Haematol Unit, Oxford OX3 9DS, England

[2] Oxford Radcliffe Hosp, Dept Cardiol, Oxford, England

[3] Oxford Radcliffe Hosp, Haemato Mol Diagnost Serv, Oxford, England

[4] Royal Bournemouth Hosp, Dept Radiol, Bournemouth, Dorset, England

[5] Oxford Radcliffe Hosp, Dept Haematol, Oxford, England

[6] Weatherall Inst Mol Med, Computat Biol Res Grp, Oxford, England

[7] Royal Bournemouth Hosp, Dept Haematol, Bournemouth, Dorset, England

来源：

BRITISH JOURNAL OF HAEMATOLOGY | 2011年 / 154卷 / 04期

关键词：

myelodysplastic syndromes; magnetic resonance imaging; transfusional iron overload; hepatic R2*; cardiac R2*; MAGNETIC-RESONANCE; MYOCARDIAL IRON; ACQUIRED ANEMIAS; THALASSEMIA; CHELATION; DISEASE;

D O I：

10.1111/j.1365-2141.2011.08749.x

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

Transfusion- dependent myelodysplastic (MDS) patients are prone to iron overload. We evaluated 43 transfused MDS patients with T2* magnetic resonance imaging scans. 81% had liver and 16.8% cardiac iron overload. Liver R2* (1000/T2*), but not cardiac R2*, was correlated with number of units transfused (r = 0.72, P < 0.0001) and ferritin (r = 0.53, P < 0.0001). The area under the curve of a time-ferritin plot was found to be much greater in patients with cardiac iron loading (median 53.7 x 10(5) Megaunits vs. 12.2 x 10(5) Megaunits, P = 0.002). HFE, HFE2, HAMP or SLC40A1 genotypes were not predictors of iron overload in these patients.

引用

页码：521 / 524

页数：4

共 50 条

[1] Diagnosis and treatment of cardiac iron overload in transfusion-dependent thalassemia patients
Siri-Angkul, Natthaphat
Chattipakorn, Siriporn C.
Chattipakorn, Nipon
EXPERT REVIEW OF HEMATOLOGY, 2018, 11 (06) : 471 - 479
[2] Iron status and treatment modalities in transfusion-dependent patients with myelodysplastic syndromes
Delforge, Michel
Selleslag, Dominik
Triffet, Agnes
Mineur, Philippe
Bries, Greet
Graux, Carlos
Trullemans, Fabienne
MacDonald, Karen
Abraham, Ivo
Pluymers, Wim
Ravoet, Christophe
ANNALS OF HEMATOLOGY, 2011, 90 (06) : 655 - 666
[3] Iron status and treatment modalities in transfusion-dependent patients with myelodysplastic syndromes
Michel Delforge
Dominik Selleslag
Agnès Triffet
Philippe Mineur
Greet Bries
Carlos Graux
Fabienne Trullemans
Karen MacDonald
Ivo Abraham
Wim Pluymers
Christophe Ravoet
Annals of Hematology, 2011, 90 : 655 - 666
[4] Cardiac effects of deferasirox in transfusion-dependent patients with myelodysplastic syndromes: TELESTO study
Sarocchi, Matteo
Li, Junmin
Li, Xiao
Wu, Depei
Figueroa, Efreen Montano
Rodriguez, Maria Guadalupe
Hou, Ming
Finelli, Carlo
Shi, Hong-Xia
Xiao, Zhijian
Oliva, Esther Natalie
Kyuchukova, Liana Gercheva
Drummond, Mark
Symeonidis, Argiris
Velazquez, Eric J.
Rivoli, Giulia
Izquierdo, Miguel
Kolekar, Yogita
Spallarossa, Paolo
Angelucci, Emanuele
BRITISH JOURNAL OF HAEMATOLOGY, 2024, 204 (05) : 2049 - 2056
[5] Effect of deferasirox on iron overload in patients with transfusion-dependent haemoglobinopathies
Fragomeno, Concetta
Roccabruna, Emilio
D'Ascola, Domenico Giuseppe
BLOOD CELLS MOLECULES AND DISEASES, 2015, 55 (04) : 382 - 386
[6] Early cardiac iron overload in children with transfusion-dependent anemias
Fernandes, Juliano Lara
Fabron, Antonio, Jr.
Verissimo, Monica
HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2009, 94 (12): : 1776 - 1777
[7] Hematologic responses to deferasirox therapy in transfusion-dependent patients with myelodysplastic syndromes
Gattermann, Norbert
Finelli, Carlo
Della Porta, Matteo
Fenaux, Pierre
Stadler, Michael
Guerci-Bresler, Agnes
Schmid, Mathias
Taylor, Kerry
Vassilieff, Dominique
Habr, Dany
Marcellari, Andrea
Roubert, Bernard
Rose, Christian
HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2012, 97 (09): : 1364 - 1371
[8] Iron Overload in Patients With Myelodysplastic Syndromes: An Updated Overview
Moukalled, Nour M.
El Rassi, Fuad A.
Temraz, Sally N.
Taher, Ali T.
CANCER, 2018, 124 (20) : 3979 - 3989
[9] Deferasirox in iron-overloaded patients with transfusion-dependent myelodysplastic syndromes: Results from the large 1-year EPIC study
Gattermann, Norbert
Finelli, Carlo
Della Porta, Matteo
Fenaux, Pierre
Ganser, Arnold
Guerci-Bresler, Agnes
Schmid, Mathias
Taylor, Kerry
Vassilieff, Dominique
Habr, Dany
Domokos, Gabor
Roubert, Bernard
Rose, Christian
LEUKEMIA RESEARCH, 2010, 34 (09) : 1143 - 1150
[10] Understanding Iron Overload: Screening, Monitoring, and Caring for Patients With Transfusion-Dependent Anemias
Ault, Patricia
Jones, Karen
CLINICAL JOURNAL OF ONCOLOGY NURSING, 2009, 13 (05) : 511 - 517

← 1 2 3 4 5 →